Literature DB >> 15636375

Symptoms of pulmonary blastomycosis: northern Wisconsin, United States.

Dennis J Baumgardner1, Sarah E Halsmer, Gina Egan.   

Abstract

OBJECTIVE: Pulmonary disease is the most common manifestation of the systemic fungal infection, blastomycosis. This study examines symptoms of pulmonary blastomycosis and possible age and gender differences in a 22-year case series.
METHODS: Laboratory-confirmed cases of blastomycosis were identified from mandatory reports to the Vilas County Health Department (1984--2001) and from hospital records and case contacts before mandated reports (November 1979--1983). Symptoms were ascertained by interviews of respondent cases (or next of kin) by using a standard form. Proportions were compared with the chi-square test or Fisher exact test.
RESULTS: One hundred seventy cases of blastomycosis (mean age 44, 56% male) were identified and pulmonary manifestations were present in 154 (91%). Of the 118 interviewed cases, the following symptoms were common: cough (90%), fever (75%), night sweats (68%), weight loss (66%), chest pain (63%), dyspnea (54%), and aches (50%). Hemoptysis occurred in 18%, and nearly all queried patients had fatigue. The dyad of cough and fever occurred in 73%, and triads of fever-cough-night sweats, fever-cough-weight loss, and fever-cough-chest pain occurred in 58%, 57%, and 51%, respectively. Among men, fever (P = .03), cough and fever (P = .03), fever-cough-weight loss (P = .03), and fever-cough-night sweats (P = .03) were less common in those 50 years of age and older. Symptoms did not vary by duration of illness.
CONCLUSIONS: Cough, fever, night sweats, weight loss, chest pain, dyspnea, and aches are common symptoms of pulmonary blastomycosis. Symptom constellations that included fever were less common in men 50 years of age and older. There was no apparent difference in symptoms between acute and chronic blastomycosis.

Entities:  

Mesh:

Year:  2004        PMID: 15636375     DOI: 10.1580/1080-6032(2004)015[0250:sopbnw]2.0.co;2

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  7 in total

1.  The differential diagnosis of pulmonary blastomycosis using case vignettes: a Wisconsin Network for Health Research (WiNHR) study.

Authors:  Dennis J Baumgardner; Jonathan L Temte; Erin Gutowski; William A Agger; Howard Bailey; James K Burmester; Indrani Banerjee
Journal:  WMJ       Date:  2011-04

2.  Risk factors for acquisition of endemic blastomycosis.

Authors:  Maxym Choptiany; Lyle Wiebe; Bill Limerick; Pete Sarsfield; Mary Cheang; Bruce Light; Greg Hammond; Kerry Macdonald; Elly Trepman; Peter Pappas; John M Embil
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

3.  Blastomyces Antigen Detection for Diagnosis and Management of Blastomycosis.

Authors:  Holly M Frost; Thomas J Novicki
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

4.  Systemic blastomycosis diagnosed by prostate needle biopsy.

Authors:  Peter M Neal; Anne Nikolai
Journal:  Clin Med Res       Date:  2008-05

5.  Clinical characteristics and outcomes in patients with pulmonary blastomycosis.

Authors:  Doug Kralt; Bruce Light; Mary Cheang; Tracy MacNair; Lyle Wiebe; Bill Limerick; Pete Sarsfield; Greg Hammond; Kerry MacDonald; Elly Trepman; John M Embil
Journal:  Mycopathologia       Date:  2008-10-19       Impact factor: 2.574

Review 6.  Cough Due to TB and Other Chronic Infections: CHEST Guideline and Expert Panel Report.

Authors:  Stephen K Field; Patricio Escalante; Dina A Fisher; Belinda Ireland; Richard S Irwin
Journal:  Chest       Date:  2017-11-28       Impact factor: 9.410

7.  Epidemiology of cryptococcal meningitis in the US: 1997-2009.

Authors:  Vasilios Pyrgos; Amy E Seitz; Claudia A Steiner; D Rebecca Prevots; Peter R Williamson
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.